NCT02799121View on ClinicalTrials.gov

A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 29, 2019

Study Completion Date

March 29, 2019

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

ReGenerCell™ Autologous Cell Harvesting Device

Trial Locations (3)

SE5 9RS

King's College Hospital, London, London

Unknown

Northwick Park Hospital, London

M13 9WL

Manchester Royal Infirmary, Manchester

Sponsors

Lead Sponsor

Avita Medical
All Listed Sponsors
lead

Avita Medical

INDUSTRY